These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10822123)

  • 21. Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries.
    Ouyang P; Tardif JC; Herrington DM; Stewart KJ; Thompson PD; Walsh MN; Bennett SK; Heldman AW; Tayback MA; Wang NY;
    Atherosclerosis; 2006 Dec; 189(2):375-86. PubMed ID: 16442114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy.
    Bush TL
    Eur Heart J; 1996 Aug; 17 Suppl D():9-14. PubMed ID: 8869876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
    Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL
    Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
    JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.
    Grady D; Applegate W; Bush T; Furberg C; Riggs B; Hulley SB
    Control Clin Trials; 1998 Aug; 19(4):314-35. PubMed ID: 9683309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
    Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
    Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Barnabei VM; Phillips TM; Hsia J
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1167-72. PubMed ID: 10595329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators.
    Espeland MA; Stefanick ML; Kritz-Silverstein D; Fineberg SE; Waclawiw MA; James MK; Greendale GA
    J Clin Endocrinol Metab; 1997 May; 82(5):1549-56. PubMed ID: 9141548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The heart and estrogen/progestin replacement study (HERS).
    Speroff L
    Maturitas; 1998 Nov; 31(1):9-14. PubMed ID: 10091199
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D;
    JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
    Espeland MA; Marcovina SM; Miller V; Wood PD; Wasilauskas C; Sherwin R; Schrott H; Bush TL
    Circulation; 1998 Mar; 97(10):979-86. PubMed ID: 9529266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence of unrecognized myocardial infarction in women with coronary heart disease.
    Shlipak MG; Elmouchi DA; Herrington DM; Lin F; Grady D; Hlatky MA;
    Ann Intern Med; 2001 Jun; 134(11):1043-7. PubMed ID: 11388817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
    Kanaya AM; Herrington D; Vittinghoff E; Lin F; Grady D; Bittner V; Cauley JA; Barrett-Connor E;
    Ann Intern Med; 2003 Jan; 138(1):1-9. PubMed ID: 12513038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.
    Cushman M; Legault C; Barrett-Connor E; Stefanick ML; Kessler C; Judd HL; Sakkinen PA; Tracy RP
    Circulation; 1999 Aug; 100(7):717-22. PubMed ID: 10449693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women's angiographic vitamin and estrogen trial: design and methods.
    Hsia J; Alderman EL; Verter JI; Rogers WJ; Thompson P; Howard BV; Cobb FR; Ouyang P; Tardif JC; Higginson L; Bittner V; Barofsky I; Steffes M; Gordon DJ; Proschan M; Younes N; Waters D
    Control Clin Trials; 2002 Dec; 23(6):708-27. PubMed ID: 12505248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen, progestogens and cardiovascular risk.
    Stefanick ML
    J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E; Kyriakides ZS; Kremastinos DTh
    J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.